How do I buy shares of NephroGenex?

Shares of NRXGQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:NRXGQ

NephroGenex (NRXGQ) Stock Price, News & Analysis

→ This company has increased its dividend every year for 54 years (From DTI) (Ad)

Free NRXGQ Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 2,000 shs
Average Volume: 26,223 shs
Market Capitalization: $36,000.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get NephroGenex alerts:

Ad The Bull Report

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

About NephroGenex Stock (OTCMKTS:NRXGQ)

NephroGenex, Inc. is a pharmaceutical company. The Company is focused on the development of therapeutics to treat kidney disease. The Company has paused the clinical program of its product candidate, oral Pyridorin, for the treatment of diabetic nephropathy. The Company was primarily focused on the Phase III Pyridorin program, and other planned clinical and nonclinical studies and other work needed to submit Pyridorin for acute kidney injury (AKI), as well as the treatment of diabetic nephropathy in patients with Type II diabetes for regulatory approval in the United States and Europe. The Company has not generated any revenues.

Ad Tips4Traders

Uncover this 2024 Hidden Gem

Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.

[Click here to subscribe] and elevate your trading today.

NRXGQ Stock News Headlines

August 24, 2023 | investing.com

Elicera Therapeutics AB (ELIC)

August 17, 2023 | investing.com

LL Lucky Games publ AB (LADYLU)

April 19, 2024 | Priority Gold (Ad)

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

July 13, 2023 | investing.com

Xinjiang Daqo New Energy Co Ltd (688303)

July 12, 2023 | investing.com

Tsukuba Bank Ltd (8338)

July 11, 2023 | investing.com

PEXA Group Ltd (PXA)

June 21, 2023 | investing.com

Kosei Securities Co Ltd (8617)

May 19, 2023 | investing.com

Nusatama Berkah Tbk PT (NTBK)

April 19, 2024 | Insiders Exposed (Ad)

This consistently signaled gains of 453%... 610%... and even 1036%...

It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.

May 19, 2023 | investing.com

Olympic Group Corp (8289)

May 18, 2023 | investing.com

Shandong Sanyuan Biotechnology Co Ltd (301206)

May 18, 2023 | investing.com

Okinawa financial Group Inc (7350)

May 18, 2023 | investing.com

Selvas Healthcare Inc (208370)

May 16, 2023 | investing.com

Al-Bad Massuot Yitzhak Ltd (ALBA)

May 16, 2023 | investing.com

Seven Utilities and Power PCL (7UP)

May 16, 2023 | investing.com

Yong Pyong Resort Corp (070960)

May 16, 2023 | investing.com

Aksa Enerji Uretim AS (AKSEN)

May 16, 2023 | investing.com

MHP Hotel AG (CDZ0)

March 30, 2023 | marketwatch.com

Renal Disease Market | Insights and Opportunities for 2023-2030

See More Headlines

Receive NRXGQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NephroGenex and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Manufacturing
Industry: Electronic Computer Manufacturing
Sub-Industry: N/A
Current Symbol: OTCMKTS:NRXGQ
Previous Symbol: NASDAQ:NRX
CUSIP: N/A
CIK: 1338095
Web: www.nephrogenex.com
Phone: +1-609-5538887
Fax: N/A
Employees: 147,000
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 12,950,000
Free Float: N/A
Market Cap: $36,000.00
Optionable: Not Optionable
Beta: N/A

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

John P. Hamill CPA
Chief Executive Officer, Chief Financial Officer

Key Competitors

View All Competitors

NRXGQ Stock Analysis - Frequently Asked Questions

How do I buy shares of NephroGenex?: Shares of NRXGQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NRXGQ) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

NephroGenex (NRXGQ) Stock Price, News & Analysis

About NephroGenex Stock (OTCMKTS:NRXGQ)

NRXGQ Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

NRXGQ Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info